MADRIGAL PHARMACEUTICALS, INC. - 10-Q Filing

Madrigal Pharmaceuticals reports third quarter 2026 financial results including updated cash positions and debt obligations.

SEC EDGAR ·

Tickers: $MDGL

Read the full article at SEC EDGAR

More Regulatory news